AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
Published September 25, 2024 · Recall initiated: August 24, 2024
Summary
FDA records drug Class III recall D-0659-2024, published September 25, 2024 and initiated August 24, 2024. Recalling firm: Rubicon Research Private Limited; Status: Ongoing; Reported quantity: 3,984 bottles; Lot: Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration
What to do
Voluntary: Firm initiated · Letter
Get an email if ACETAZOLAMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ACETAZOLAMIDE
- Manufacturer
- Rubicon Research Private Limited
- Distributor
- Nationwide in the US
- UPC
- 0372888047010
- Lot
- Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDABliss Tree Ragi Butter Murukku 200g UPC:8906087451754. Packaged in a box, 13 boxes per case Bliss Tree RagiSeptember 25, 2024
- FDABliss Tree Millet Butter Murukku 200g UPC:8906087451631. Packaged in box, 13 boxes per cases. Bliss TreeSeptember 25, 2024
- FDABiolox Option Taper Sleeve, Type 1 Taper, -6mm Neck - Indicated for use in total hip replacement with cementedSeptember 18, 2024
- FDABiolox Option Taper Sleeve, Type 1 Taper, Standard Neck - Indicated for use in total hip replacement withSeptember 18, 2024
- FDANEUROSIGN Disposable Stimulating Dissector, REF 5888-00September 18, 2024
- FDAAcetaZOLAMIDE Tablets, USP 125 mg 100 Tablets Rx only NDC 23155-287-01 Manufactured for: HeritageJune 2, 2021
Questions about this recall
Was AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01 recalled?
Yes. FDA published recall D-0659-2024 on September 25, 2024. Reported hazard: Discoloration
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ACETAZOLAMIDE. UPC: 0372888047010.